Anand Kumaresh Tharmaratnam
Chief Executive Officer & Chairman at Novotech
London, England, United Kingdom
Find your path to Anand
248 people in our graph share verified history with Anand — schools, employers, funds. One of them is your warm intro.
About
Anand Kumaresh Tharmaratnam is Chairman and Chief Executive Officer of Novotech Health Holdings, having previously served as the company's Chairman from April 2021 to December 2025. Trained as an anaesthesiologist, he qualified as a medical doctor at University College London and worked in anaesthesia and critical care with the UK National Health Service before entering the industry in 1997, spending 23 years at Quintiles, where he led the growth of its Asia Pacific and Japan CRO business and was part of the executive team during its 2013 NYSE listing and 2016 merger with IMS Health to form IQVIA. From 2020 to 2025 he was a senior healthcare advisor to TPG Capital Asia, and he currently advises Holmusk, ObvioHealth, and Clerkenwell Health, serving as a board observer at the latter two.
Chief Executive Officer & Chairman at Novotech
Intro paths
In turn, Anand can intro founders to Novotech's investors below.
Novotech's investors · 4
Experience
- NovotechChairman and Chief Executive Officercurrent2026 — present
- Novotech Health HoldingsChairman of the Boardcurrent2021 — present
- ObvioHealthBoard Observercurrent2022 — present
- HolmuskAdvisor to Holmuskcurrent2017 — present
- AskDrT LimitedIndependent advisor for life-science management and investorscurrent2020 — presentGreater London, England, United Kingdom
- Clerkenwell HealthBoard Observer and Advisor2024 — 2026
- TPGSenior Advisor to TPG2020 — 2026Greater London, England, United Kingdom
- Pathology Asia HoldingsDirector2020 — 2026
- SaamaAdvisor to Saama2021 — 2022
- IQVIAPresident Asia Pacific2016 — 2020Singapore
- IQVIAPresident and Head of Asia-Pacific2015 — 2016UK, Singapore, US
- IQVIASenior Vice President and Head of Asia Markets2012 — 2015Singapore
- IQVIASenior Vice President and Head of Clinical Development, Asia-Pacific2010 — 2012Singapore
- IQVIASenior Vice President and Head of Clinical Development, Southeast Asia, Taiwan and South Korea2004 — 2010Singapore
- IQVIASenior Vice President, Alliance Management, Quintiles Japan2003 — 2004Tokyo, Japan
- IQVIAHead, ECG Lab2001 — 2003Mumbai Metropolitan Region
- IQVIAMedical Director, Quintiles Europe1999 — 2001London Area, United Kingdom
- IQVIAClinical Pharmacologst1997 — 1999Quintiles Guys Drug Research Unit, London, United Kingdom
Skills & more
+12 more
PharmacologyLifesciencesInfectious DiseasesNeurosciencePsychiatryR&DCorporate DevelopmentTherapeutic AreasStrategyCROPharmaceutical IndustryCTMSFrom Anand's professional profile.
Frequently asked questions
- Who is Anand Kumaresh Tharmaratnam?
- Anand Kumaresh Tharmaratnam is Chairman and Chief Executive Officer of Novotech Health Holdings, having previously served as the company's Chairman from April 2021 to December 2025. Trained as an anaesthesiologist, he qualified as a medical doctor at University College London and worked in anaesthesia and critical care with the UK National Health Service before entering the industry in 1997, spending 23 years at Quintiles, where he led the growth of its Asia Pacific and Japan CRO business and was part of the executive team during its 2013 NYSE listing and 2016 merger with IMS Health to form IQVIA. From 2020 to 2025 he was a senior healthcare advisor to TPG Capital Asia, and he currently advises Holmusk, ObvioHealth, and Clerkenwell Health, serving as a board observer at the latter two.
- Where does Anand Kumaresh Tharmaratnam work?
- Anand Kumaresh Tharmaratnam is Chief Executive Officer & Chairman at Novotech.
- Where did Anand Kumaresh Tharmaratnam go to school?
- Anand Kumaresh Tharmaratnam studied at Royal College of Anaesthetists (MRCA, Membership RCA); UCL (MBBS, Medicine); Sevenoaks School (0 and A levels).
Same school
Also attended UCL706
+ 700 more
Also attended Sevenoaks School28
+ 22 more
Shared employers
Also worked at Holmusk7
+ 1 more
